valproic acid has been researched along with fenfluramine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Hudson, JI; Pope, HG | 1 |
| Aicardi, J; Gastaut, H; Misès, J | 1 |
| Lerer, B | 1 |
| Ceulemans, B; Copmans, D; Crawford, AD; de Witte, PA; Esguerra, CV; Kecskés, A; Lagae, L; Langlois, M; Zhang, Y | 1 |
| Boyd, B; Farfel, GM; Galer, BS; Gammaitoni, A; Smith, S | 1 |
| Ferretti, A; Pietrafusa, N; Specchio, N; Trivisano, M; Vigevano, F | 1 |
| Conway, E; Devinsky, O; King, L; Price, D; Schwartz, D | 1 |
| Ceulemans, B; Maes, P; Schoonjans, A | 1 |
| Bonaventura, CD; Capovilla, G; Coppola, A; Elia, M; Ferlazzo, E; Gobbi, G; Marini, C; Meletti, S; Riva, A; Romeo, A; Santoro, K; Striano, P; Verrotti, A | 1 |
| Battino, D; Bromley, R; Kochen, S; Meador, KJ; Pennell, PB; Thomas, SV; Tomson, T | 1 |
| Schubert-Bast, S; Strzelczyk, A | 1 |
4 review(s) available for valproic acid and fenfluramine
| Article | Year |
|---|---|
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Feeding and Eating Disorders; Fenfluramine; Humans; Hyperphagia; Lithium; Lithium Carbonate; Methamphetamine; Monoamine Oxidase Inhibitors; Nomifensine; Phenytoin; Placebos; Propiophenones; Valproic Acid | 1986 |
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgyline; Demeclocycline; Fenfluramine; Humans; Methylene Blue; Phosphatidylcholines; Physostigmine; Propiophenones; Propranolol; Spironolactone; Thyroxine; Tryptophan; Valproic Acid | 1985 |
Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force
Topics: Breast Feeding; Cannabidiol; Carbamazepine; Child; Clobazam; Clonazepam; Epilepsy; Ethosuximide; Everolimus; Felbamate; Female; Fenfluramine; Gabapentin; Humans; Infant; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Prospective Studies; Tiagabine; Topiramate; Valproic Acid; Vigabatrin; Zonisamide | 2022 |
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Topics: Autism Spectrum Disorder; Bromides; Cannabidiol; Clobazam; Cognition; Ethosuximide; Everolimus; Felbamate; Fenfluramine; Humans; Lacosamide; Lamotrigine; Levetiracetam; Pregabalin; Spasms, Infantile; Sulfides; Topiramate; Valproic Acid; Vigabatrin; Zinc Compounds; Zonisamide | 2022 |
2 trial(s) available for valproic acid and fenfluramine
| Article | Year |
|---|---|
Antidepressant drug therapy for bulimia: current status.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Feeding and Eating Disorders; Fenfluramine; Humans; Hyperphagia; Lithium; Lithium Carbonate; Methamphetamine; Monoamine Oxidase Inhibitors; Nomifensine; Phenytoin; Placebos; Propiophenones; Valproic Acid | 1986 |
A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
.
Topics: Administration, Oral; Adult; Clobazam; Cross-Over Studies; Dioxolanes; Drug Interactions; Female; Fenfluramine; Healthy Volunteers; Humans; Male; Middle Aged; Non-Smokers; Valproic Acid; Young Adult | 2019 |
10 other study(ies) available for valproic acid and fenfluramine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Syncopal attacks compulsively self-induced by Valsalva's maneuver associated with typical absence seizures. A case report.
Topics: Apnea; Child; Child Behavior; Compulsive Behavior; Electroencephalography; Epilepsy, Absence; Female; Fenfluramine; Humans; Syncope; Valproic Acid; Valsalva Maneuver | 1988 |
Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsies, Myoclonic; Fenfluramine; Gene Knockdown Techniques; Humans; Morpholinos; NAV1.1 Voltage-Gated Sodium Channel; Oligonucleotides, Antisense; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Zebrafish; Zebrafish Proteins | 2015 |
Successful use of fenfluramine in nonconvulsive status epilepticus of Dravet syndrome.
Topics: Anticonvulsants; Child; Clobazam; Drug Therapy, Combination; Epilepsies, Myoclonic; Fenfluramine; Humans; Male; NAV1.1 Voltage-Gated Sodium Channel; Point Mutation; Selective Serotonin Reuptake Inhibitors; Status Epilepticus; Valproic Acid | 2020 |
Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Epilepsies, Myoclonic; Epilepsy, Tonic-Clonic; Epileptic Syndromes; Female; Fenfluramine; Humans; Lethargy; Male; Seizures; Spasms, Infantile; Treatment Outcome; Valproic Acid; Young Adult | 2021 |
Aggravation of valproic acid induced thrombocytopenia after the introduction of fenfluramine, a case report.
Topics: Anemia; Anticonvulsants; Fenfluramine; Humans; Thrombocytopenia; Valproic Acid | 2021 |
An Italian consensus on the management of Lennox-Gastaut syndrome.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Consensus; Fenfluramine; Humans; Lamotrigine; Lennox Gastaut Syndrome; Quality of Life; Topiramate; Valproic Acid | 2022 |